AccurKardia
Evolutionary technology is setting the standard for AI-powered heart rhythm analytics and diagnostics.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD17—25m (Dealroom.co estimates Jun 2023.)
New York City New York (HQ)
Financials
Estimates*
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | <1m | <1m | <1m |
| % growth | - | 14 % | 25 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
| N/A | N/A | Seed | |
| N/A | $450k | Seed | |
| N/A | $1.4m | Seed | |
* | $2.7m | Seed | |
* | N/A | - | |
| Total Funding | AUD7.0m | ||
Recent News about AccurKardia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.